BRPI0519139A2 - liberaÇço controlada de entidades biolàgicas - Google Patents
liberaÇço controlada de entidades biolàgicasInfo
- Publication number
- BRPI0519139A2 BRPI0519139A2 BRPI0519139-4A BRPI0519139A BRPI0519139A2 BR PI0519139 A2 BRPI0519139 A2 BR PI0519139A2 BR PI0519139 A BRPI0519139 A BR PI0519139A BR PI0519139 A2 BRPI0519139 A2 BR PI0519139A2
- Authority
- BR
- Brazil
- Prior art keywords
- controlled release
- biological entity
- biological entities
- biological
- polar phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
- B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
- B01J2/08—Gelation of a colloidal solution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21001—Chymotrypsin (3.4.21.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01005—Urease (3.5.1.5)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LIBERAÇçO CONTROLADA DE ENTIDADES BIOLàGICAS. A presente invenção refere-se a um processo para encapsular, de maneira que possa ser liberada, uma entidade biológica. O processo compreende combinar uma solução de um tensoativo em um solvente não polar com um material precursor e com a entidade biológica para formar uma emulsão. A emulsão compreende uma fase polar dispersa em uma fase não polar, em que a fase polar compreende a entidade biológica. As partículas compreendem a entidade biológica são então formadas partindo da fase polar.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004907219A AU2004907219A0 (en) | 2004-12-20 | Controlled release of biological entities | |
PCT/AU2005/001915 WO2006066317A1 (en) | 2004-12-20 | 2005-12-20 | Controlled release of biological entities |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519139A2 true BRPI0519139A2 (pt) | 2008-12-30 |
Family
ID=36601253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519139-4A BRPI0519139A2 (pt) | 2004-12-20 | 2005-12-20 | liberaÇço controlada de entidades biolàgicas |
Country Status (10)
Country | Link |
---|---|
US (2) | US8992986B2 (pt) |
EP (1) | EP1838289B1 (pt) |
JP (2) | JP5593030B2 (pt) |
KR (1) | KR20070104563A (pt) |
CN (1) | CN101106978A (pt) |
BR (1) | BRPI0519139A2 (pt) |
CA (1) | CA2591344C (pt) |
MX (1) | MX2007007373A (pt) |
NZ (1) | NZ556082A (pt) |
WO (1) | WO2006066317A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6101683A (en) | 1998-04-02 | 2000-08-15 | Avery Dennison Corporation | Loop fastener, fastener clip including same and loop fastener dispensing tool |
WO2009132411A1 (en) * | 2008-04-28 | 2009-11-05 | The University Of British Columbia | Polymer-free drug delivery system for implantable medical devices |
US9222060B2 (en) | 2009-03-27 | 2015-12-29 | Australian Nuclear Science And Technology Organisation | Triggered release |
CA2808019C (en) * | 2010-08-16 | 2019-12-03 | Australian Nuclear Science & Technology Organisation | Particulate substances comprising ceramic particles for delivery of biomolecules |
US10001501B2 (en) | 2015-12-31 | 2018-06-19 | Universal Diagnostics, S. L. | Systems and methods for automated, customizable sample preparation for detection of metabolites and lipids |
CN107522868B (zh) * | 2017-10-16 | 2021-01-08 | 湖北工业大学 | 环氧纳米二氧化硅/嵌段聚合物复合乳液的制备方法 |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3850751A (en) * | 1973-02-16 | 1974-11-26 | Corning Glass Works | Enzymes immobilized on porous inorganic support materials |
CH624011A5 (pt) | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
CA1253129A (en) | 1984-02-09 | 1989-04-25 | Thomas R. Jones | Porous inorganic materials |
JPH0717371B2 (ja) * | 1986-09-05 | 1995-03-01 | 株式会社資生堂 | 球状の有機複合粘土鉱物及びその製造法 |
JPH05261274A (ja) | 1992-03-23 | 1993-10-12 | Lion Corp | 金属化合物の球形粒子の製造方法 |
JP3310291B2 (ja) | 1992-08-13 | 2002-08-05 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 骨組織のin vitro合成のための生物活性物質テンプレート |
US5817327A (en) | 1994-07-27 | 1998-10-06 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US6096324A (en) * | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
US6764690B2 (en) | 1996-05-29 | 2004-07-20 | Delsitech Oy | Dissolvable oxides for biological applications |
US5972384A (en) | 1997-10-01 | 1999-10-26 | University Of Maryland, Baltimore | Use of biologically active glass as a drug delivery system |
IL141411A0 (en) | 1998-08-13 | 2002-03-10 | Sol Gel Technologies Ltd | Method for the preparation of oxide microcapsules loaded with functional molecules and the product obtained thereof |
US6395299B1 (en) | 1999-02-12 | 2002-05-28 | Biostream, Inc. | Matrices for drug delivery and methods for making and using the same |
EP1188057B1 (en) | 1999-06-24 | 2008-01-23 | McMASTER UNIVERSITY | Incorporation and applications of biomolecular interactions within a carrier |
JP2001038193A (ja) * | 1999-07-28 | 2001-02-13 | Nippon Millipore Kk | 複合シリカマイクロカプセルの製造方法と複合シリカマイクロカプセルの芯物質の固定化と徐放作用の制御方法。 |
AU7881000A (en) | 1999-08-16 | 2001-03-13 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
AUPQ573300A0 (en) * | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
US6303290B1 (en) | 2000-09-13 | 2001-10-16 | The Trustees Of The University Of Pennsylvania | Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process |
US6485707B2 (en) | 2001-02-15 | 2002-11-26 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
US6544497B2 (en) | 2001-02-15 | 2003-04-08 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
US6596262B2 (en) | 2001-02-15 | 2003-07-22 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
AU2002364701B8 (en) | 2001-11-20 | 2006-06-22 | Alkermes, Inc. | Compositions for sustained action product delivery |
JP4192235B2 (ja) * | 2002-04-30 | 2008-12-10 | 独立行政法人産業技術総合研究所 | 徐放機能を有するメソポーラス無機材料 |
WO2003092402A1 (en) * | 2002-04-30 | 2003-11-13 | Solae, Llc | Method of imparting high water dispersibility to protein materials and the products thereof |
EP1549294A1 (en) * | 2002-10-11 | 2005-07-06 | Vectura Limited | Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
JP2005307120A (ja) * | 2004-04-26 | 2005-11-04 | Mitsubishi Chemicals Corp | 徐放剤及びそれを用いた徐放材 |
MX2007005775A (es) * | 2004-11-15 | 2007-08-15 | Australian Nuclear Science Tec | Particulas solidas provenientes de la desestabilizacion controlada de microemulsiones. |
US20090098044A1 (en) * | 2004-11-15 | 2009-04-16 | Australian Nuclear Science And Technology Organisation | Solid particles from controlled destabilisation of microemulsions |
-
2005
- 2005-12-20 US US11/721,728 patent/US8992986B2/en not_active Expired - Fee Related
- 2005-12-20 JP JP2008518535A patent/JP5593030B2/ja not_active Expired - Fee Related
- 2005-12-20 BR BRPI0519139-4A patent/BRPI0519139A2/pt not_active Application Discontinuation
- 2005-12-20 KR KR1020077016764A patent/KR20070104563A/ko active Search and Examination
- 2005-12-20 EP EP05818407.8A patent/EP1838289B1/en not_active Not-in-force
- 2005-12-20 CN CNA2005800470576A patent/CN101106978A/zh active Pending
- 2005-12-20 NZ NZ556082A patent/NZ556082A/en not_active IP Right Cessation
- 2005-12-20 CA CA2591344A patent/CA2591344C/en active Active
- 2005-12-20 WO PCT/AU2005/001915 patent/WO2006066317A1/en active Application Filing
- 2005-12-20 MX MX2007007373A patent/MX2007007373A/es active IP Right Grant
-
2012
- 2012-11-05 JP JP2012243686A patent/JP5727445B2/ja not_active Expired - Fee Related
-
2015
- 2015-02-03 US US14/612,739 patent/US9717688B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20150147401A1 (en) | 2015-05-28 |
JP5593030B2 (ja) | 2014-09-17 |
US8992986B2 (en) | 2015-03-31 |
EP1838289B1 (en) | 2017-12-13 |
JP5727445B2 (ja) | 2015-06-03 |
US20090252808A1 (en) | 2009-10-08 |
CN101106978A (zh) | 2008-01-16 |
MX2007007373A (es) | 2007-08-14 |
CA2591344A1 (en) | 2006-06-29 |
US9717688B2 (en) | 2017-08-01 |
KR20070104563A (ko) | 2007-10-26 |
CA2591344C (en) | 2015-09-29 |
EP1838289A4 (en) | 2011-12-14 |
NZ556082A (en) | 2009-09-25 |
WO2006066317A1 (en) | 2006-06-29 |
JP2008538217A (ja) | 2008-10-16 |
WO2006066317A8 (en) | 2006-08-24 |
EP1838289A1 (en) | 2007-10-03 |
JP2013047264A (ja) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519139A2 (pt) | liberaÇço controlada de entidades biolàgicas | |
UY30701A1 (es) | Sistemas espesados con surfactantes, compuestos de celulosa micro fibrosa, y metodos para fabricarlos | |
BR112014029762A2 (pt) | composição contendo n-metil-n-acilglucamina | |
BRPI0605260A (pt) | processo de fabricação de toner livre de solvente utilizando inversão de fase | |
BR112012011534A2 (pt) | materiais de liberação de blenda de fluorossilicone | |
CY1117721T1 (el) | Κυτταρα προελευσης αμνιακου υγρου | |
CL2011001419A1 (es) | Procedimiento para separar por lo menos un primer material de una mezcla, que comprende contactar la mezcla con una sustancia de superficie activa, tratar la dispersión con partículas magnéticas hidrófobas para que formen aglomerados con el primer material y la sustancia, separar los aglomerados y disociar dichos aglomerados | |
BR112012006635B8 (pt) | composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas | |
BR112015028883A2 (pt) | encapsulados | |
CL2008002269A1 (es) | Composicion util para tratar plantas, que comprende un medio oleoso que contiene particulas de 1- metil - ciclopropeno encapsulado por un agente encapsulador, siendo dichas particulas de 50 micrometros o menos y donde el medio oleoso comprende ademas uno o más dispersante. | |
BR112012010650A2 (pt) | partícula de liberação | |
BRPI0514538A (pt) | composição para cuidado oral, e, processo para a produção de uma composição para cuidado oral | |
BRPI0912020A2 (pt) | composições e métodos de incorporação de fotocatalisadores | |
BR112012011248A2 (pt) | processo para separar pelo menos um primeiro material de uma mistura | |
BR112015001652A2 (pt) | composição melhorada de protetor solar de alta proteção | |
AR075716A1 (es) | Separacion magnetica de minerales metalicos no ferrosos por acondicionamiento en multiples etapas | |
UY36157A (es) | Composiciones pesticidas y procedimientos relacionados con las mismas | |
BR112013026183A2 (pt) | processo de determinação da concentração em oxigênio intersticial | |
NO20075555L (no) | Fremgangsmate for fremstilling av fosfolipider | |
BR112012029644A2 (pt) | composições de decapagem e métodos de realizar e usar os mesmos | |
BRPI0512594A (pt) | extração, por solvente, de poliidroxialcanoato de biomassa | |
CL2012000241A1 (es) | Composición para disminuir el material particulado en suspensión en aire o un líquido que comprende una fuente de exopolisacáridos (eps), una cepa de microorganismos con actividad ureolítica y medio de cultivo; método para disminuir material particulado en suspensión en aire o un líquido que comprende aplicar dicha composición. | |
AR072359A1 (es) | Encapsulacion de agentes biologicamente activos | |
BR112014004263A2 (pt) | composições fixadoras de cabelo | |
BR112015001664A2 (pt) | composição melhorada de protetor solar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |